// App-Quantinova.ai

e23140 : The effects of the first in class steroid sulfatase inhibitor Irosustat on FLT uptake and Ki67 in estrogen receptor positive early breast cancer: Results of the perioperative IPET study.

Researchers

Presenter

  • Carlo Palmieri

Principal Investigators

  • Richard Szydlo

  • Marie Miller

  • Laura Woodley-Barker

  • Neva Patel

  • Tara Berwick

  • Henry Tam

  • Dimitri Hadjiminas

  • Jasmin Lee

  • Abeer Shaaban

  • Sadie Reed

  • Hanna Nicholas

  • Charles Coombes

  • Laura M. Kenny

Medical Centers

  • Institute of Translational Medicine, Liverpool, United Kingdom

  • Imperial College, London, United Kingdom

  • University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom

  • Imperial College, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Proliferation marker protein Ki-67

Drug/Treatment

  • Irosustat

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT01662726

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved